CompaniesNew England Cell Therapeutics

New England Cell Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

9

By Phase

PHASE2: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

2028

2029

Today

Hover over trial bars to see details

Recent Trials

NCT06910384Lead Sponsor

A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)

PHASE2Recruiting

Started: Aug 12, 2025 · Completed: Jan 30, 2028